These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19417609)

  • 1. Pleiotropic effects of morphine-6beta-glucuronide.
    Lötsch J
    Anesthesiology; 2009 Jun; 110(6):1209-10. PubMed ID: 19417609
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
    van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
    Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid regulation of pallidal enkephalin release: bimodal effects of locally administered mu and delta opioid agonists in freely moving rats.
    Olive MF; Maidment NT
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1310-6. PubMed ID: 9618438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-pot multicomponent approach to a new series of morphine derivatives and their biological evaluation.
    Shao J; Houghten RA; Dooley CT; Cazares M; McLaughlin JP; Eans SO; Ganno ML; Hoot MR; Giulianotti MA; Yu Y
    Org Biomol Chem; 2017 Sep; 15(37):7796-7801. PubMed ID: 28875208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects.
    Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Nakamura M; Mizutani K; Inagaki N; Sasano M; Aono H
    Eur J Pharmacol; 2010 Nov; 647(1-3):62-7. PubMed ID: 20813108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects on dopamine release in nucleus accumbens in mice by the morphine metabolites morphine-6-glucuronide and morphine-3-glucuronide.
    Vindenes V; Pettersen BS; Gottås A; Christiansen NL; Boix F; Mørland J
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):357-60. PubMed ID: 19663818
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.
    Brissett DI; Whistler JL; van Rijn RM
    Eur J Pain; 2012 Mar; 16(3):327-37. PubMed ID: 22337177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice.
    Scherrer G; Befort K; Contet C; Becker J; Matifas A; Kieffer BL
    Eur J Neurosci; 2004 Apr; 19(8):2239-48. PubMed ID: 15090050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.